76.71

2.70% -2.13

Globus Medical Inc (GMED)

Overview News Price History Option Chain Financials Discussions Forecast

Globus Medical Inc stock is traded at $76.71, with a volume of 1.94M. It is down -2.70% in the last 24 hours and up +1.93% over the past month. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Previous Close:

$78.84

Open:

$79.35

24h Volume:

1.94M

Relative Volume:

1.24

Market Cap:

$10.30B

Revenue:

$3.10B

Net Income/Loss:

$586.71M

P/E Ratio:

17.87

EPS:

4.2937

Net Cash Flow:

$605.57M

1W Performance:

+2.76%

1M Performance:

+1.93%

6M Performance:

-17.30%

1Y Performance:

+30.97%

1-Day Range:

$76.49

$79.95

1-Week Range:

$74.61

$79.95

52-Week Range:

$58.32

$101.40

Globus Medical Inc Stock (GMED) Company Profile

Name

Globus Medical Inc

Sector

Healthcare (1052)

Industry

Medical Devices (143)

Phone

610-930-1800

Address

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Employee

6,000

Twitter

@GlobusMedical

Next Earnings Date

2026-11-05

Latest SEC Filings

GMED's Discussions on Twitter

Compare GMED vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GMED Globus Medical Inc	76.71	10.30B	3.10B	586.71M	605.57M	4.2937
ABT Abbott Laboratories	104.89	181.50B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.75	121.20B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	294.66	113.02B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	44.39	64.33B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.60	49.92B	6.30B	1.07B	1.09B	1.8406

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-28-26	Initiated	UBS	Neutral
Jul-09-26	Initiated	BMO Capital Markets	Outperform
Jan-30-26	Upgrade	Needham	Hold → Buy
Jan-27-26	Initiated	TD Cowen	Buy
Nov-07-25	Upgrade	BofA Securities	Neutral → Buy
Nov-07-25	Upgrade	Truist	Hold → Buy
Oct-28-25	Resumed	Stifel	Hold
May-27-25	Downgrade	BTIG Research	Buy → Neutral
Jan-10-25	Upgrade	BofA Securities	Underperform → Neutral
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	ROTH MKM	Buy
Sep-19-23	Upgrade	Stifel	Hold → Buy
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Feb-10-23	Downgrade	Loop Capital	Buy → Hold
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Truist	Buy → Hold
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Apr-13-22	Resumed	Truist	Buy
Mar-28-22	Initiated	Wells Fargo	Overweight
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Oct-29-21	Initiated	Loop Capital	Buy
Feb-18-21	Resumed	Needham	Buy
Dec-08-20	Initiated	Citigroup	Buy
Oct-20-20	Initiated	Stifel	Hold
Aug-06-20	Reiterated	Needham	Buy
Aug-06-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-21-20	Initiated	Northland Capital	Market Perform
Jul-06-20	Downgrade	Piper Sandler	Overweight → Neutral
May-08-20	Reiterated	Needham	Buy
Mar-18-20	Upgrade	BTIG Research	Neutral → Buy
Jan-08-20	Initiated	SunTrust	Buy
Dec-12-19	Upgrade	Wells Fargo	Market Perform → Outperform
Aug-02-19	Reiterated	Needham	Buy
May-24-19	Downgrade	Wells Fargo	Outperform → Market Perform
May-03-19	Reiterated	Needham	Buy
Feb-28-19	Upgrade	UBS	Neutral → Buy
Jan-02-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-02-18	Reiterated	Needham	Buy
Jun-27-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
May-03-18	Reiterated	Needham	Buy
Apr-04-18	Upgrade	Needham	Hold → Buy

View All

Globus Medical Inc Stock (GMED) Latest News

Oct 16, 2026

GMED or AXGN: Which Is the Better Value Stock Right Now? - Zacks Investment Research

Oct 16, 2026

Reasons to Add STE Stock to Your Portfolio Right Now - Zacks Investment Research

Oct 16, 2026

Haemonetics Gains 149.3% in a Year: What's Driving the Rally? - Zacks Investment Research

Oct 16, 2026

Is it Apt to Retain Medtronic Stock in Your Portfolio Now? - Zacks Investment Research

Oct 16, 2026

Oct 15, 2026

Is Spine Tech Unveiling Altering The Investment Case For Globus Medical Stock? - Yahoo Finance

Oct 15, 2026

RBC cuts target to USD 85.00 for Globus Medical stock - ad-hoc-news.de

Oct 15, 2026

BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients - Zacks Investment Research

Oct 15, 2026

Doximity Deepens U.S. News Alliance to Improve Patient Access to Care - Zacks Investment Research

Oct 15, 2026

Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research

Oct 15, 2026

Is Globus Medical (GMED) Cheap On Its Spine Platform Reveal? - Yahoo Finance

Oct 15, 2026

What Does Globus Medical (GMED) Mean For Spine Care After Its NASS 2026 Reveal? - Yahoo Finance

Oct 15, 2026

Oct 14, 2026

Globus Medical (GMED) Stock Looks Discounted Against Its Earnings Outlook - Yahoo Finance

Oct 14, 2026

Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026 - Orthopedics This Week

Oct 14, 2026

Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally? - Zacks Investment Research

Oct 14, 2026